| Literature DB >> 33888612 |
Iain C Clark1,2, Cristina Gutiérrez-Vázquez1, Michael A Wheeler1,3, Zhaorong Li1,3, Veit Rothhammer1,4, Mathias Linnerbauer1,4, Liliana M Sanmarco1, Lydia Guo1, Manon Blain5, Stephanie E J Zandee6, Chun-Cheih Chao1, Katelyn V Batterman7, Marius Schwabenland8, Peter Lotfy1,3, Amalia Tejeda-Velarde1, Patrick Hewson1, Carolina Manganeli Polonio1, Michael W Shultis1, Yasmin Salem1, Emily C Tjon1, Pedro H Fonseca-Castro1, Davis M Borucki1, Kalil Alves de Lima1, Agustin Plasencia1, Adam R Abate9,10, Douglas L Rosene7, Kevin J Hodgetts1, Marco Prinz8,11,12, Jack P Antel5, Alexandre Prat6, Francisco J Quintana13,3.
Abstract
Cell-cell interactions control the physiology and pathology of the central nervous system (CNS). To study astrocyte cell interactions in vivo, we developed rabies barcode interaction detection followed by sequencing (RABID-seq), which combines barcoded viral tracing and single-cell RNA sequencing (scRNA-seq). Using RABID-seq, we identified axon guidance molecules as candidate mediators of microglia-astrocyte interactions that promote CNS pathology in experimental autoimmune encephalomyelitis (EAE) and, potentially, multiple sclerosis (MS). In vivo cell-specific genetic perturbation EAE studies, in vitro systems, and the analysis of MS scRNA-seq datasets and CNS tissue established that Sema4D and Ephrin-B3 expressed in microglia control astrocyte responses via PlexinB2 and EphB3, respectively. Furthermore, a CNS-penetrant EphB3 inhibitor suppressed astrocyte and microglia proinflammatory responses and ameliorated EAE. In summary, RABID-seq identified microglia-astrocyte interactions and candidate therapeutic targets.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33888612 PMCID: PMC8157482 DOI: 10.1126/science.abf1230
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728